Impact of borderline (BL) pulmonary hypertension (PH) in chronic lung diseases (CLD). Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020
Diagnostic value of induced sputum (IS) in interstitial lung disease (ILD) Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007
Prevalence rates of symptoms and diagnoses of chronic bronchitis (CB), emphysema (E) and asthma (A), with or without airflow obstruction (AO), in two Italian general population samples Source: Eur Respir J 2005; 26: Suppl. 49, 595s Year: 2005
Hedgehog-interacting protein (HHIP ) polymorphisms and chronic obstructive pulmonary disease (COPD)Source: Annual Congress 2011 - Genetic and environmental risk factors for respiratory diseases Year: 2011
The difference between surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with chronic obstructive pulmonary disease acute exacerbations (AE COPD) and community acquired pneumonia (CAP) Source: International Congress 2014 – Clinical presentations Year: 2014
Association between AGTTGFB1ESR1, and VDR gene variants with idiopathic pulmonary fibrosis (IPF) and pulmonary sarcoidosis (PS) clinical features Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases Year: 2017
Enhanced apoptosis of alveolar lymphocytes (AL), but not macrophages (AM) in interstitial idiopathic pneumonias (IIPs). Special attention to idiopathic pulmonary fibrosis (IPF) results Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010
Clinical implications of diagnosing underlying chronic bronchitis (CB) in at-risk patients (pts) with acute bronchitis (AB) visiting general practitioners (GPs) Source: Annual Congress 2008 - Wider aspects of managing respiratory disease in primary care Year: 2008
Pulmonary embolism (PE) in patients with pulmonary sarcoidosis (PS) Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014
Differential therapy of acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD) patients with predominance of emphysema (PE) and predominance of bronchitis (PB) Source: Eur Respir J 2006; 28: Suppl. 50, 395s Year: 2006
CD8 BAL lymphocytosis differentiates usual interstitial pneumonia (UIP) from sarcoidosis (SA); correlation with clinical parameters Source: Eur Respir J 2001; 18: Suppl. 33, 195s Year: 2001
Mucociliary clearance (MCC) disorders in patient with acute bronchitis (AB) and acute exacerbation (AE) of COPD and ways of it correction Source: Annual Congress 2009 - Drug effects in COPD Year: 2009
30 years experience of plasmapheresis using in complex treatment of pulmonary sarcoidosis (PS) Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014
Markers of inflammation and pulmonary function (PF) in sarcoidosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010
Diagnostic values of inflammation biomarkers in pleural effusions (PE) Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015
Clinical and epidemiological characteristics of chronic obstructive pulmonary disease (COPD) patients in Spain (VICE Study) Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006
Microbiological features of the indicators of bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) during remission Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019
Contribute of BAL proteomic analysis in sarcoidosis (S) and in idiopathic pulmonary fibrosis (IPF/UIP) Source: Eur Respir J 2006; 28: Suppl. 50, 564s Year: 2006
Difference in immunological aspects of inflammation in idiopathic pulmonary fibrosis (IPF) and exogenous toxic alveolitis (ETA) Source: Eur Respir J 2003; 22: Suppl. 45, 121s Year: 2003
The clinical significance of markers of endothelial dysfunction (ED) inprogression of idiopathic interstitial pneumonias (IIP) Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011